Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Oculus Innovative Sciences Announces Preliminary Results From 40-Patient Feasibility Study For Treatment Of Acne With The Microcyn(R) Technology
Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, announced that preliminary results from its U.S. 40-patient feasibility study, in which an enhanced formulation of the company"s Microcyn Technology-based hydrogel was used in the treatment of acne, are highly encouraging and warrant further examination.
generic viagra online
Traumatic Brain Injury Treated By Alzheimer's Disease Drug
The destructive cellular pathways activated in Alzheimer"s disease are also triggered following traumatic brain injury, say researchers from Georgetown University Medical Center (GUMC). They say this finding suggests that novel therapy might successfully target both conditions.
News of the day
New Jersey Senate Passes Bill Requiring Pharmacists To Tell Consumers If Generic Drugs Can Replace Brand-Name Prescriptions
The New Jersey Senate on Thursday unanimously passed legislation (A 2030) that would require pharmacists to inform consumers when they have substituted generic drugs for brand-name prescriptions, the Newark Star-Ledger reports. The General Assembly approved the legislation in February and it now moves to Gov. Jon Corzine (D).If Corzine signs the bill, the law would take effect within 180 days, making New Jersey the first state in the U.S. to have such a requirement. State Sen. Christopher Bateman (R) said, "We"re hoping that other states will follow our lead" (Megerian, Newark Star-Ledger, 5/22).
Mental Health

CEMACH Release: New Results On The Perinatal Mortality Rate

The latest figures from the Confidential Enquiry into Maternal and Child Health (CEMACH) Perinatal Mortality Surveillance Report 2007 show improvements in the stillbirth and neonatal death rates in the UK. The main findings are: - For the first time since 2000, a significant fall in the stillbirth rate from 5.7 per 1,000 births in 2002 - 2004 to 5.2 per 1, 000 births in 2007. - The lowest neonatal death rate since 2000 (3.3 per 1, 000 live births). - Similar improvements in the stillbirth and neonatal death rates among twins. - A higher proportion of post mortem examinations being offered for stillbirths and neonatal deaths compared to previous years, although this has been offset by a higher proportion of parents/guardians refusing to have an examination. Information obtained from a post mortem examination can contribute to understanding the possible cause of a perinatal death which may help to inform future care. Maternal age was noted to be a significant risk factor for stillbirths, perinatal and neonatal death and the figures also show an increasing trend of later motherhood: - Teenage mothers (Notes To view a pdf of the Fifth Annual Perinatal Mortality Report, please click here. This is the first time CEMACH has provided perinatal mortality statistics for the whole of the UK, allowing for benchmarking between Trusts. Previous reports held data on all stillbirths and neonatal deaths in England, Wales and Northern Ireland, the Channel Islands and the Isle of Man, provided by the Office for National Statistics. This new report includes data from Scotland, gathered in collaboration with NHS Quality Improvement Scotland. CEMACH will become an independent charity on 1 July 2009 with the new name Centre for Maternal and Child Enquiries (CMACE). The RCOG will continue to support the work of CMACE. For more information, please click here. Confidential Enquiry into Maternal and Child Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009